Kaplan–Meier analysis indicated a significantly better prognosis in HCC cases with low PKM2 expression, in terms of overall survival (P < 0.0001), disease-free survival (P = 0.001) and recurrence-free survival (P = 0.007) in the training cohort. This evidence concerns the gene PKM and hepatocellular carcinoma.